CYP 0.00% 26.0¢ cynata therapeutics limited

"Good vibes Here Dudes"....., page-78

  1. 6,970 Posts.
    lightbulb Created with Sketch. 1289
    Anyway.....back to having Good times here dudes....

    https://cynata.com/news/cynata-gets-the-green-light-for-phase-2-agvhd-trial

    https://www.theaustralian.com.au/business/*/asx-health-stocks-cynata-gets-fda-green-light-for-phase-2-share-price-up-10pc/news-story/3e268bb1a51c039c9646ff43bb4c828e?btr=a176d4f264f091bc26ebb8b423b70d59

    https://hotcopper.com.au/data/attachments/6320/6320308-5e83cf46f4825130c81c4461abd7468f.jpg
    https://hotcopper.com.au/data/attachments/6320/6320329-fc840409dea624a5f71bf65cc26cb5a9.jpg

    Turkey and the US are both countries that aren't Australia. Same, same.



    If it's no longer a big deal, then, fair enough, I suppose.

    It didn't commence by the end of that year, either, but that's ok, too. Silly Ross and his....words.


    "Cynata is looking A-OK"...."good vibes here dudes". Quite hip and groovy comments.


    KK said recently that either GVHD or OA will be the first to commercialise. This was an update, where previously, Ross had nominated that GVDH was likely to commercialise first and Ross was even quoted as saying that (with Fujiilm) he expected to commecialise around the beginning of 2024. Ross and his words, again.

    Does anyone want to discuss/speculate when OA or GVHD will likely commercialise? Even with all things being equal and everything running to plan from here?

    I have my own calculation but I'm interested to hear from those more in touch with what goes on over here in Cynata land?
 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
(20min delay)
Last
26.0¢
Change
0.000(0.00%)
Mkt cap ! $46.70M
Open High Low Value Volume
26.0¢ 26.5¢ 26.0¢ $22.52K 86.65K

Buyers (Bids)

No. Vol. Price($)
1 34500 25.5¢
 

Sellers (Offers)

Price($) Vol. No.
26.5¢ 8292 2
View Market Depth
Last trade - 15.25pm 19/07/2024 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.